Publications
- Nailfold capillaroscopy in systemic sclerosis: Data from the EULAR scleroderma trials and research (EUSTAR) database2013 | First Faculty of Medicine
- Collagen and elastin degradation products as potential activity markers of scleroderma2009 | First Faculty of Medicine, Third Faculty of Medicine
- Leflunomide in the therapy of active rheumatoid arthritis2004 | First Faculty of Medicine
- Clinical correlation of potential markers of the systemic scleroderma activity2003 | First Faculty of Medicine
- What should an angiologist know about immunosuppressive therapy?Publication without faculty affiliation
- Clinical correlations of potential activity markers in systemic sclerosisPublication without faculty affiliation
- Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?2024 | First Faculty of Medicine
- Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study2023 | Faculty of Physical Education and Sport, First Faculty of Medicine
- S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin2023 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial2023 | First Faculty of Medicine
Loading network view...